The Hatter Cardiovascular Institute has developed into one of the world’s leading centres for the study of cardiovascular disease and is credited with pioneering discoveries on how to protect the heart from damage during a heart attack.

Based on our expertise gained in cardiovascular disease, we have developed additional research programmes focusing on:

  1. Neuroprotection specific to ischaemic stroke
  2. The cardio-renal syndrome, addressing the impact on the heart from chronic kidney disease
  3. Cardio-oncology, investigating how best to reduce the damage to the heart following chemotherapy.

Within our framework, as part of UCL’s overall Institute of Cardiovascular Science, we undertake basic and clinical research at the highest level, train clinical and basic scientist and continue to strive to improve the treatment options available to patients.
 

Research
clickable image that leads to research information regarding the hatter institute

Research

The Hatter Cardiovascular Institute leads research in heart protection, stroke, and cardio-oncology, advancing understanding for real-world impact.

Education
clickable image that leads to information about hatter institute's educational activities

Education

The Hatter Cardiovascular Institute is a founder and key supporter of educational platforms both locally and internationally.

Team
clickable image that leads to information about hatter institute's team

Team

Meet the Hatter Cardiovascular team.

Director 

Professor Derek Yellon 

image of professor derek yellon

CONTACT

Hatter Cardiovascular Institute

67 Chenies Mews

London

WC1E 6HX

General Enquiries:

Sara Giesz

Operations Manager

Telephone: +44 (0)20 3447 9888

Email: s.giesz@ucl.ac.uk